Nasus Pharma Ltd.(NSRX)
$2.91-0.07 (-2.51%)
NSRX
Nasus Pharma Ltd. financials statements
$2.91
At close:-0.07 (-2.51%)
Want to see NSRX full AI Analyst Report?
Nasus Pharma Ltd. (NSRX) Ratios
28 Followers
Nasus Pharma Ltd. Ratios
NSRX's free cash flow for Q2 2026 was $-1.99M. For the 2026 fiscal year, NSRX's free cash flow was decreased by $-1.32K and operating cash flow was $-1.99M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 2.24 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 2.24 | 0.00 | 0.00 | 0.00 |
| Cash Ratio | 0.57 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | -2.62 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Ratio | -2.27 | 0.00 | 0.00 | 0.00 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 2.62M | $ 0.00 | $ 0.00 | $ 0.00 |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.02 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.04 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.04 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.81 | 0.00 | 0.00 | 0.00 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | -37.17 | -23.41 | -113.44 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.23 | 0.00 | 0.00 | 0.00 |
| Profitability Margins | ||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.88% | 98.71% | 104.58% | 79.51% |
| EBT Per EBIT | 118.37% | 143.97% | 87.62% | 105.39% |
| Return on Assets (ROA) | -117.03% | 0.00% | 0.00% | 0.00% |
| Return on Equity (ROE) | -211.56% | 0.00% | 0.00% | 0.00% |
| Return on Capital Employed (ROCE) | -172.62% | 0.00% | 0.00% | 0.00% |
| Return on Invested Capital (ROIC) | -169.92% | 0.00% | 0.00% | 0.00% |
| Return on Tangible Assets | -117.03% | 0.00% | 0.00% | 0.00% |
| Earnings Yield | -7.99% | -2.05% | -1.41% | -2.29% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -0.61 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Per Share | -0.62 | 0.00 | 0.00 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | -351.29 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -351.29 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -41.68 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -6.73% | 0.00% | 0.00% | 0.00% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -12.71 | -48.53 | -71.12 | -43.68 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 26.48 | 0.00 | 0.00 | 0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -14.86 | 0.00 | 0.00 | 0.00 |
| Price-to-Operating Cash Flow Ratio | -14.90 | 0.00 | 0.00 | 0.00 |
| Price-to-Earnings Growth (PEG) Ratio | -0.04 | -1.16 | 1.93 | 0.00 |
| Enterprise Value Multiple | -14.72 | 0.00 | 0.00 | 0.00 |
| Enterprise Value | 72.17M | 0 | 0 | 0 |
| EV to EBITDA | -14.72 | 0.00 | 0.00 | 0.00 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -14.63 | 0.00 | 0.00 | 0.00 |
| EV to Operating Cash Flow | -14.68 | 0.00 | 0.00 | 0.00 |
| Tangible Book Value Per Share | 0.35 | 0.00 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | 0.35 | 0.00 | 0.00 | 0.00 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.73 | -0.17 | -0.12 | -0.19 |
| Tax Burden | 1.01 | 0.99 | 1.05 | 0.80 |
| Interest Burden | 1.18 | 1.02 | 1.05 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.85 | 0.00 | 0.00 | 0.00 |
Currency in USD
